We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.
ContinueLearn More X
17 Jan 20
The new manufacturing facility is designed to have advanced features based on the efficiency of the existing facilities…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
13 Jan 20
Lilly will expanding its portfolio of Phase 3 medicines with the addition of lebrikizumabfor for atopic dermatitis and…
Asset ManagementActive Pharmaceutical Ingredients and IntermediatesPharmaceuticals
23 Sep 19
Rybelsus is currently being reviewed by various regulatory agencies across the world, including the European Medicines Agency and…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
06 Sep 19
Phase III trial TAGS is designed to evaluate LONSURF in combination with best supportive care (BSC), with placebo…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
27 Aug 19
The closing of the transaction is subject to the signing of a consent decree by Bristol-Myers Squibb and…
21 Aug 19
The FDA acceptance is based on the previously announced positive results of two global Phase 3 studies in…
PharmaceuticalsActive Pharmaceutical Ingredients and Intermediates
Alzheimer’s disease is the most common cause of dementia, which currently affects over 46.8 million people across the…
Amsterdam Airport Schiphol aims to be Europe’s leading centre for pharmaceutical transportation. Jonas van Stekelenburg, head of cargo,…
Randox Laboratories is a global leader in healthcare diagnostics, with 5% of the world’s population receiving medical diagnosis…
The properties of cannabis have been used in food and herbal medicine for centuries. MH medical hemp produces…
Active Pharmaceutical Ingredients and IntermediatesNutraceuticals